27 September 2017 - The Biosafety Council issues a positive advice (with conditions) for this trial
File:
Trial reference:
A Phase 1b Study of Talimogene Laherparepvec in Combination With Atezolizumab in Subjects With Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases